Description
Composition- Vildagliptin 50 mg + Metformin 500 mg
Mode of Action- Combines DPP-4 inhibition with metformin action to improve insulin secretion, reduce glucagon and lower hepatic glucose output.
USPs- Dependable dual antidiabetic support; effective in early to moderate type 2 diabetes; supports stable glycemic control.
Prescribing Specialties- Diabetologist, General Physician
